The rising impact of angiogenesis research

Arjan W. Griffioen, Andrew C. Dudley

Research output: Contribution to journalEditorialAcademicpeer-review

1 Citation (Scopus)


While inhibiting pathological angiogenesis has been long associated with the field of oncology, recent advances in angiogenesis research have impacted the progress of disease treatment for additional non-malignant diseases or chronic conditions in the fields of ophthalmology, cardiology, and gynecology. Moreover, stimulators of angiogenesis find application in ischemic diseases, while inhibitors of angiogenesis are being used to limit blood vessel formation, but in judicious ways that modify or “reprogram” the vasculature as a reinforcement for immunotherapy. We have noticed an increasing impact, as evidenced by increases in the total number of citations, in the literature surrounding the angiogenesis field suggesting that targeting angiogenesis per se is well established as a tractable approach for therapy in diverse conditions.
Original languageEnglish
Pages (from-to)435-437
Number of pages3
Issue number4
Early online date2022
Publication statusPublished - Nov 2022

Cite this